Caribou Biosciences (CRBU) EBT: 2020-2025
Historic EBT for Caribou Biosciences (CRBU) over the last 6 years, with Sep 2025 value amounting to -$29.4 million.
- Caribou Biosciences' EBT rose 23.11% to -$29.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$158.8 million, marking a year-over-year increase of 3.88%. This contributed to the annual value of -$149.1 million for FY2024, which is 46.37% down from last year.
- According to the latest figures from Q3 2025, Caribou Biosciences' EBT is -$29.4 million, which was up 38.21% from -$47.6 million recorded in Q2 2025.
- In the past 5 years, Caribou Biosciences' EBT registered a high of -$13.2 million during Q1 2021, and its lowest value of -$47.6 million during Q2 2025.
- Over the past 3 years, Caribou Biosciences' median EBT value was -$38.2 million (recorded in 2024), while the average stood at -$36.6 million.
- As far as peak fluctuations go, Caribou Biosciences' EBT slumped by 644.59% in 2021, and later skyrocketed by 44.86% in 2023.
- Caribou Biosciences' EBT (Quarterly) stood at -$18.2 million in 2021, then slumped by 68.40% to -$30.6 million in 2022, then fell by 22.45% to -$37.4 million in 2023, then dropped by 3.83% to -$38.9 million in 2024, then grew by 23.11% to -$29.4 million in 2025.
- Its EBT stands at -$29.4 million for Q3 2025, versus -$47.6 million for Q2 2025 and -$42.9 million for Q1 2025.